This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Antares Pharma Reports Second Quarter 2012 Financial And Operating Results

Stocks in this article: ATRS

TABLES FOLLOW

 

ANTARES PHARMA, INC.
CONSOLIDATED CONDENSED BALANCE SHEETS
(amounts in thousands)
   
June 30, December 31,
2012 2011
Assets
Cash and investments $ 33,017 $ 34,396
Accounts receivable 2,630 2,535
Patent rights 1,044 952
Goodwill 1,095 1,095
Other assets   4,762   2,985
Total Assets $ 42,548 $ 41,963
 
Liabilities and Stockholders’ Equity
Accounts payable and accrued expenses $ 4,739 $ 4,364
Deferred revenue 3,440 6,455
Stockholder’s equity   34,369   31,144
Total Liabilities and Stockholders’ Equity $ 42,548 $ 41,963
 
 
ANTARES PHARMA, INC.
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
(amounts in thousands except per share amounts)
   
For the Three Months Ended For the Six Months Ended
June 30, June 30,
2012   2011 2012   2011
Product sales $ 3,212 $ 2,219 $ 5,706 $ 3,624
Development revenue 737 716 3,723 1,772
Licensing revenue 109 119 735 485
Royalties   466     489     1,224     1,231  
Total Revenue 4,524 3,543 11,388 7,112
 
Cost of revenue   2,531     1,393     4,521     2,846  
Gross Profit 1,993 2,150 6,867 4,266
 
Research and development 2,483 1,946 5,360 3,696
Sales, marketing and business development 420 523 855 812
General and administrative   1,881     1,277     3,539     2,766  
Total Operating Expenses   4,784     3,746     9,754     7,274  
 
Operating loss (2,791 ) (1,596 ) (2,887 ) (3,008 )
 
Other income and expenses   (16 )   42     6     73  
 
Net loss $ (2,807 ) $ (1,554 ) $ (2,881 ) $ (2,935 )
 
Basic and diluted net loss per common share $ (0.03 ) $ (0.02 ) $ (0.03 ) $ (0.03 )
 
Basic and diluted weighted average common shares outstanding

104,552

95,157

104,105

90,464

 




4 of 5

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs